Nifty slips 0.15% as Tata stocks and IT weigh on Indian equities

Indian equities enter Thursday’s session after a cautious close, with the market’s weakness concentrated in Tata Group stocks and information technology rather than reflecting a broad loss of support. The main shock was N Chandrasekaran’s decision not to seek reappointment as Tata Sons chairman after his current term ends on February 20, 2027. TCS came under the sharpest pressure, while Tata Motors Passenger Vehicles, Tata Steel, Tata Consumer Products, Tata Power and Titan also weakened.

The sell-off was compounded by crude remaining close to the $90-a-barrel area as uncertainty over the reopening of the Strait of Hormuz persisted. That combination raised concerns about imported inflation and corporate input costs. A late recovery, led by financial stocks and value buying, limited the damage but did not remove the overhang from oil or the leadership uncertainty around the Tata Group.

Banks provided the clearest counterweight to the selling. State Bank of India and other public-sector lenders attracted buying on views that stronger asset quality, relatively attractive valuations and a healthy credit-growth outlook could support earnings. The banking rebound helped the financial complex finish more resiliently than the broader market.

Power stocks also found support, with Power Grid among the notable gainers. The sector’s relative strength came despite weakness in Tata Power, showing that the move was not uniform across the group. Telecom and internet-linked names were comparatively firm, while the broader market remained selective rather than directional.

Information technology was the main drag after TCS fell sharply in reaction to the Tata Sons announcement; Infosys was also among the large-cap laggards. Healthcare weakness was sharper in hospital stocks after reports related to possible caps on charges, while PI Industries’ weak quarter added to pressure in parts of the pharma complex. The consumer-durables decline was part of broader stock-specific and earnings-related selling; a single sector-wide trigger was not available in the material.

The July consumer-price data supplied a mixed signal for monetary policy. Headline CPI rose to 4.45% from 4.38% in June, while food inflation accelerated to 5.52% from 5.32%. Rural inflation remained higher than urban inflation. The print was close to expectations on headline inflation, but the food component was hotter than the reported poll estimate.

The reading remains within the Reserve Bank’s tolerance band, and market commentary indicated that it was unlikely to alter expectations of an extended policy pause. The implication for Indian assets is two-sided: contained headline inflation preserves room for policy stability, but persistent food inflation and the risk of higher energy costs leave less comfort on the inflation path.

SEBI said it was reviewing position limits and margin requirements in commodity derivatives and examining calibrated wider access for foreign portfolio investors to physically settled non-agricultural commodity derivatives. Any eventual change would matter mainly through market participation, hedging costs and liquidity rather than through an immediate earnings effect for listed companies. No separate RBI or finance ministry market-moving action was available in the material.

Overseas cues were mixed. US equities ended unevenly as investors weighed softer July US inflation against renewed oil and geopolitical concerns. Asian markets were also divided: Chinese technology shares provided support, while Hong Kong equities remained under pressure. For India, the global setup offers some support from easing US inflation concerns, but the oil and shipping-risk channel remains more immediate.

Higher crude is particularly relevant for India because it can pressure the import bill, inflation expectations, margins of energy-intensive companies and the rupee. The rupee nevertheless strengthened on the session. The benchmark government bond yield was little changed, suggesting that the inflation and oil risks had not yet produced a decisive repricing in the domestic rate market.

Foreign institutional investors were net sellers of Indian equities on August 12, while domestic institutions were strong net buyers. The resulting institutional balance softened the market’s decline, but the reversal in foreign flows leaves overseas risk appetite and the next moves in oil and US yields important for the opening tone.

The corporate news flow remained highly uneven. Apollo Hospitals reported first-quarter profit and revenue above the cited poll estimates, supported by higher inpatient volumes and occupancy. Astral’s profit and EBITDA beat estimates, although revenue was slightly below the poll forecast, pointing to better operating leverage but not a clean top-line beat.

PI Industries reported a weaker quarter, with revenue, EBITDA and profit lower year on year and margins narrowing. Management commentary cited adverse order mix, strategic-order phasing and higher domestic execution costs, while the outlook remained more back-ended toward the second half. The result helps explain weakness in the stock and the broader pressure on parts of the chemicals and agrochemicals space.

Tata Motors’ commercial-vehicle business reported a strong increase in first-quarter profit and revenue and flagged price increases. Bata India also reported higher profit on modest revenue growth, while Marksans Pharma posted sharp growth in profit, revenue and margins. In contrast, Godrej Consumer Products faced management-transition uncertainty after Sudhir Sitapati stepped down as managing director and chief executive, with Aasif Malbari appointed to the roles.

Primary-market activity remains active. Milky Mist Dairy Food’s offer closes on August 13 after strong early demand, while the Sham Foam issue also closes the same day. Credent Connect N Care opens on Thursday, and Behari Lal Engineering remains in its subscription window.

The reported Metropolis Healthcare blocks involved promoter-related sellers and mutual-fund buyers, making the transaction notable for ownership transfer rather than a fresh primary-equity issue. The market will also have to absorb another large batch of quarterly results, including Tata Motors Passenger Vehicles and several healthcare, financial and consumer names.